relapse
121 results
1 - 100
relapse- marker-only relapse
- recrudescence
inebilizumab- satralizumab
- recurrence
- dimethyl fumarate
- ublituximab
- esketamine
- ocrelizumab/hyaluronidase
- peginterferon alfa-2B
- eflornithine (systemic)
- recidivity
- PART
- ocrelizumab
- palindromia
- diroximel fumarate
- monomethyl fumarate
- alemtuzumab
- disease-free survival
- salvage therapy
- marker
- tositumomab (I 131 tositumomab)
- peginterferon beta-1a
- duration of response
- interferon beta-1a
- cladribine
- AMPHOTERICIN B
- recidivation
- tafenoquine
- retrocession
- interferon beta-1b
- vincristine liposome
- minimal residual disease
- ISOtretinoin
- dalfampridine
- response
- HFimpEF
Antithyrotropin Receptor Antibodies: Binding Inhibition Antibodies and Stimulating Antibodies- ravulizumab
- tretinoin (systemic)
- eculizumab
- gallium nitrate
- L-tryptophan
- pseudorelapse of multiple sclerosis
- varenicline (systemic)
- epinephrine
- griseofulvin
- artemether-lumefantrine
- alendronate
- nystatin (oral)
- acamprosate
Multiple Sclerosis- PACLitaxel
- mefloquine
- pamidronate
- interferon alpha-2b
- onychomycosis
- Guillain-Barré Syndrome
- Cholinesterases: Acetylcholinesterase, Pseudocholinesterase and Dibucaine Number
- dermatitis
- Myasthenia Gravis
- lansoprazole
- Aplastic Anemia
- Cytomegalovirus Infection
- dexlansoprazole
- dupilumab
- brentuximab vedotin
- vonoprazan
- Syphilis
- IgG4-related systemic disease
- doxapram
- etidronate
- Bladder Cancer
- ganciclovir
- Lupus Erythematosus
- Mikulicz-Radecki, Johann von
- Tonsillitis